NCT01708850View on ClinicalTrials.gov

Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

June 30, 2016

Conditions
NeoplasmCentral Venous Catheter Thrombosis
Interventions
DRUG

Rivaroxaban

All specified in arm description. One arm study.

Trial Locations (1)

N6A5W9

London Health Sciences Centre, London

Sponsors
All Listed Sponsors
lead

London Health Sciences Centre

OTHER